1. Caruso, F., Hyeon, T. & Rotello, V. M. Nanomedicine. Chem. Soc. Rev. 41, 2537–2538 (2012).
2. McDonald, T. O. et al. in Global Approaches to Health and Safety Issues (ed. Dolez, P. I.) (Elsevier, 2015).
3. Owen, A. & Rannard, S. Considerations for clinically-relevant nanomedicine therapies for chronic diseases. Nanomedicine 20, 3109–3119 (2015).
4. Sosnik, A., Seremeta, K. P., Imperiale, J. C. & Chiappetta, D. A. Novel formulation and drug delivery strategies for the treatment of pediatric poverty-related diseases. Expert Opin. Drug Deliv. 9, 303–323 (2012).
5. World Health Organisation. Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV. ISBN 978 92 4 150956 5 (2015).